Advertisement

Topics

Study Confirms Value of Idarucizumab in Reversing Blood Thinner Dabigatran

20:00 EDT 1 Aug 2017 | AHC Media

A new study confirms the effectiveness and safety of an agent that reverses the action of the blood thinner dabigatran.

Original Article: Study Confirms Value of Idarucizumab in Reversing Blood Thinner Dabigatran

NEXT ARTICLE

More From BioPortfolio on "Study Confirms Value of Idarucizumab in Reversing Blood Thinner Dabigatran"

Quick Search
Advertisement